Newcells Biotech raises £2.35m for lab models that help avoid animal testing

A Newcastle life sciences company has secured a £2.35m investment to help ramp up its work on laboratory models that help avoid animal testing.
Founded in 2015, the Newcastle University spin-out Newcells Biotech is leading the way in the development of human stem cells for the drug development sector, using models which aim to reduce the reliance on animal testing. Based at the Biosphere at Newcastle Helix, the firm has secured the seven-figure funding from existing investors, including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds and Northstar Ventures – funds wh …